SDPR Inhibits TGF-β Induced Cancer Metastasis Through Fatty Acid Oxidation Regulation in Gastric Cancer

Xiaoyue Li1, Jing Luo2, Kelin Mou1

  • 1Department of Oncology, The Affiliated Hospital of Southwest Medical University, Sichuan, Luzhou, 644000, China.

Insights

Transforming growth factor-β (TGF-β) signaling impacts gastric cancer metastasis. This study reveals serum deprivation protein response (SDPR) is downregulated, inhibiting fatty acid metabolism and offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • Transforming growth factor-β (TGF-β) is implicated in tumor metastasis.
  • Serum deprivation protein response (SDPR) is a potential TGF-β target, but its role in gastric cancer is unknown.

Purpose of the Study:

  • To investigate the role and mechanism of SDPR in gastric cancer.
  • To elucidate the involvement of SDPR in TGF-β-mediated tumor metastasis and gastric cancer metabolism.

Main Methods:

  • Gene microarray and bioinformatic analysis.
  • In vivo and in vitro experimental validation.
  • Investigation of protein interactions and pathway analysis (ERK/PPAR).

Main Results:

  • SDPR is significantly downregulated in gastric cancer.
  • SDPR interacts with extracellular signal-regulated kinase (ERK) and suppresses the ERK/PPAR pathway.
  • SDPR inhibits the expression of Carnitine palmitoyl transferase 1A (CPT1A), a key gene in fatty acid metabolism.

Conclusions:

  • The TGF-β/SDPR/CPT1A axis is crucial for fatty acid oxidation in gastric cancer.
  • SDPR dysregulation impacts tumor microenvironment and metabolic reprogramming.
  • Targeting fatty acid metabolism presents a potential therapeutic strategy for gastric cancer metastasis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K